David joined Providence Ventures as a Partner in 2018 where he has helped lead the formulation of the firm’s medical device investment strategy. David also helps support investment strategy and decision processes in software and service focused businesses.

Prior to joining PV, David worked for River Cities Capital Fund (“RCCF”), one of the most active and experienced growth equity funds in healthcare and information technology. David most recently was a Principal on the healthcare team having served on deal teams across medical devices, software, and services.

Additionally, David served as President and Board Member of Mid-America Health Investors Network (MHIN), where he represented over 60 active healthcare funds with offices spread throughout Middle America.

David currently or previously served as a Board Director, Board Observer, or co-led financings for TailorMed, MacroHealth, OrthAlign Inc., AVIA Health, NICO Corp., Wildflower Health, Bolder Surgical (acquired by Hologic), Veran Medical (acquired by Olympus), TissueTech (sold to financial sponsor), and Advanced Practice Strategies (acquired by Relias Learning).

Earlier in his career, David served as a principal, sales associate, and investment advisor with American Financial Group and completed extensive financial, consumer branding, and sales and marketing programs with Merrill Lynch and Procter & Gamble.

David graduated from Indiana University’s Kelley School of Business and received his MBA with a concentration in finance from Xavier University’s Williams College of Business.

David and his family remain active in the Seattle and Cincinnati communities supporting various initiatives targeting behavioral health, education and youth programs, veteran affairs, and medical research programs.